What Cerebrum DAO does

Cerebrum DAO is a decentralized autonomous organization (DAO) founded in 2023 and headquartered in Zürich, Switzerland, that operates as a community-powered funding mechanism for translational neuroscience research, with an initial focus on preventing neurodegeneration and Alzheimer's disease. The organization enables community members to collectively identify, fund, and govern neuroscience projects through the NEURON governance token (86 billion total supply, 38.7 billion circulating) and IP-NFT (Intellectual Property Non-Fungible Token) tokenization using Molecule's protocol. As of available data, Cerebrum DAO has deployed approximately $1.3 million across 7 research projects, including Percepta ($400K brain health supplement), Fission Bio ($400K protein-protein interaction inhibitors), Project Transfidelity ($254K protein synthesis at University of Zurich), Arctic Therapeutics (€75K Alzheimer's therapeutics), SK Channels ($60K Chapman University), Acta Pharmaceuticals ($100K equity), and Xponetiq ($50K consumer brain health app).

The organization operates a community-led go-to-market model where token holders participate in governance via Snapshot voting across working groups (Translational Neuroscience, Product, Coordination & Operations, Community & Awareness). Its technology stack includes Ethereum L1 and Base L2 deployment, with NEURON tokens traded on Uniswap and Aerodrome, and project-level IP governance tokens (CLAW, MITY, FIDEL, GALE) representing fractional rights over specific research IP portfolios. Revenue mechanics are forward-looking and contingent: IP licensing proceeds from companies developing therapeutics based on funded research, equity exits from spun-out neuroscience startups, and token utility fees from NEURON holders' preferential access to IP token sales and brain health products. Notable strategic collaborations include exclusive licensing agreements with Chapman University (KCa2.2 ion channel modulators) and Nacuity Pharmaceuticals (NACA for Alzheimer's), plus research collaborations with Harvard Medical School, UCL, and the UT Dallas Center for Brain Health.

Name

Cerebrum DAO

Legal name

Cerebrum DAO Association

Website

https://cerebrumdao.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Cerebrum DAO is a Zürich-based decentralized autonomous organization that uses the NEURON governance token and IP-NFT tokenization to community-fund translational neuroscience research focused on Alzheimer's and neurodegeneration, deploying capital across seven projects and partnerships with Harvard, UCL, and Chapman University.

Ownership category

akta.pro rank

Product category

Decentralized Biotechnology Research Funding

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Finance Services (6199), Investors, Nec (6799)

akta.pro primary industry

Grants, Funding & Budget Allocation Platforms (FSAPAHAE)

akta.pro secondary industries

Coordination & Contributor Management (tasks, bounties, roles) (FSAPAHAD), DAO Treasury, Governance & On-Chain Finance Tools (FSADAMAL), Governance Frameworks & DAO Tooling (modules, templates, standards) (FSAPAHAC)

Keywords

• Decentralized science funding
• Biotechnology research funding
• Intellectual property tokenization
• Neuroscience research DAO
• Brain health therapeutics

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Token Sale Proceeds: Cerebrum DAO is funded by the sale of NEURON tokens to members of the public. Private sales raised initial operating capital from strategic partners. Public sales were hosted on BIO Launchpad (bio.xyz). The token is now available for secondary market trading.
2. IP Licensing and Commercialization: IP from funded projects is tokenized using IPNFT protocol. Licensed to companies interested in developing new therapeutics, with proceeds distributed between researchers and the DAO. The DAO may also spin out discoveries into new neuroscience startups.
3. Token Utility Revenue: NEURON token holders receive exclusive early access to IP token sales for IP-NFT projects, discounted access to brain health products, and prioritized access to therapeutics as they come to market from the IP portfolio.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Cerebrum DAO is a community-governed decentralized autonomous organization that funds translational neuroscience research to prevent neurodegeneration, with an initial focus on Alzheimer's disease. It raises capital through the NEURON governance token and deploys funds into research projects via IP-NFT tokenization, equity investments, and product development, while distributing IP license and governance rights back to its community of token holders. Funded projects include brain health supplements, therapeutic drug programs, and neuroscience-based mobile applications.

Differentiator

Problem solved

Functional benefit

Products and services

• NEURON Token Governance and utility token of Cerebrum DAO with 86 billion total supply; provides voting power for DAO proposals, exclusive early access to IP token sales, discounted access to brain health products, and prioritized access to therapeutics developed from the IP portfolio. Available for trading on Uniswap (Ethereum) and Aerodrome (Base).
• Percepta Patent-protected brain health natural dietary supplement with active ingredients PTI-00703 Cat's claw and MemorTea oolong tea extract; backed by a $400,000 Cerebrum DAO IP Portfolio License investment.
• Xponetiq App Neuroscience-based mobile application for building brain-healthy habits through daily quests; developed by 21 Impact Labs using licensed neuroscience from the UT Dallas Center for Brain Health.
• CLAW Token (NEURON-Percepta IPT)

Quantifiable outcome

• 6.7 million Americans currently living with Alzheimer's disease
• +4 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Molecule AGcoreTechnology or IntegrationMolecule provides the IP-NFT (Intellectual Property Non-Fungible Token) protocol that Cerebrum DAO uses to tokenize research IP. This enables equitable distribution of license and governance rights to the community. The partnership allows for the creation of IP tokens (IPTs) representing fractional governance rights over intellectual property portfolios.
• VitaDAOcoreStrategic or Co-development PartnerCerebrum DAO has co-funded projects with VitaDAO, including Fission Bio. VitaDAO is a decentralized biotech DAO focused on longevity research. The partnership enables joint funding of neuroscience projects and knowledge sharing within the DeSci ecosystem.
• BIO ProtocolcoreGTM or Marketing PartnerBIO Protocol is a decentralized science (DeSci) platform built on Ethereum that enables community-driven funding and governance of biotechnology research. Cerebrum DAO is part of the BioDAO ecosystem under BIO Protocol. BIO Launchpad hosted the NEURON token public sale.
• DeSci CollectiveminorGTM or Marketing PartnerDeSci Collective is a podcast and community platform for decentralized science. Listed as a partner supporting progress in brain health.
• What.digitalminorOthersWhat.digital provides digital marketing services and support for Cerebrum DAO communications and brand initiatives.
• Harvard ResearcherscoreStrategic or Co-development PartnerSenior researchers from Harvard Medical School and Mass General collaborate with Arctic Therapeutics (a Cerebrum DAO-funded project) on AT-001 development for Alzheimer's treatment.
• UCL ResearcherscoreStrategic or Co-development PartnerUniversity College London researchers collaborate with Arctic Therapeutics on neurodegenerative disease research, providing scientific expertise and research capabilities.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerCollaborating institution on Neuron-Gale galectin-3 inhibitor project, providing research expertise in neuroinflammation and Alzheimer's disease.
• University of Texas at Dallas Center for Brain HealthcoreStrategic or Co-development PartnerXponetiq app is based on licensed neuroscience from UT Dallas Center for Brain Health, enabling the app to help users build brain-healthy habits through daily quests.
• Nacuity PharmaceuticalscoreOEM/ Whitelabel/ Licensing PartnerExclusive licensing agreement for NACA (N-acetylcysteine amide) development in neurological disorders, key to Arctic Therapeutics' AT-001 Alzheimer's treatment.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• VitaDAO: VitaDAO is a decentralized autonomous organization funding longevity research through community governance and IP-NFT tokenization — the same DeSci model Cerebrum DAO uses, making it the most direct peer in structure and mission (lonvity vs. brain health).
• AthenaDAO: AthenaDAO is a DeSci DAO funding women's health research through token-based governance and IP tokenization — directly comparable in structure (community-funded biotech DAO) but focused on a different therapeutic vertical.
• HairDAO: HairDAO is a DeSci DAO focused on hair-loss research using the same community-governance and IP-NFT framework as Cerebrum DAO, but in a smaller, consumer-adjacent therapeutic vertical.
• PsyDAO: PsyDAO is a DeSci DAO funding psychedelic and mental health research with token-based governance, comparable to Cerebrum DAO in governance model and IP-tokenization approach, with overlapping brain-health themes.
• GenomesDAO: GenomesDAO is a DeSci DAO enabling individuals to monetize genomic data for research, using token-based governance and IP tokenization comparable to Cerebrum DAO's community-owned research-funding model.

Broad incumbents

• Molecule (Molecule AG): Molecule developed the IP-NFT protocol that Cerebrum DAO uses and operates a broader platform for tokenizing biotech IP across multiple DAOs; it is both a core technology partner and a broader incumbent in the DeSci IP-tokenization category.
• BIO Protocol: BIO Protocol is the parent DeSci ecosystem and launchpad that hosted Cerebrum DAO's NEURON public sale. It is a broader incumbent coordinating many BioDAOs across different therapeutic areas.

Emerging players

• LabDAO: LabDAO is a decentralized science DAO focused on enabling shared lab infrastructure and computational biology tools for DeSci communities, providing adjacent infrastructure rather than directly funding therapeutics like Cerebrum DAO.
• ResearchHub: ResearchHub is a decentralized scientific research platform that incentivizes scientists to share and review research, sharing the community-driven research ethos with Cerebrum DAO but without a treasury/IP-tokenization model.
• Pump Science: Pump Science is a DeSci launchpad and longevity-supplements protocol on Solana that funds and commercializes scientific compounds — a more consumer/longevity-focused analogue to Cerebrum DAO's supplement IP-NFT (Percepta/CLAW).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/Cerebrum_DAO
• LinkedInlinkedin.com/company/cerebrum-dao

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cerebrum DAO